bupivacaine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
MARCAIN 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 48329
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
22 Aug 2023
to
13 Oct 2023

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative brands available.
MARCAIN 0.25% WITH ADRENALINE 1:400,000 20mL injection vial
AUST R: 125878
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
06 Jun 2023
to
30 Jun 2023

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule
AUST R: 123384
Active ingredients:
bupivacaine hydrochloride
fentanyl citrate

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
01 May 2023

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability